Inventor
CALDERON IMELDA
US12 patents
⚠️ This page may combine multiple inventors who share the name “CALDERON IMELDA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
4 patentsUS7132426B2Nov 7, 2006
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC56 citations95
US7838525B2Nov 23, 2010
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC39 citations92
US7470699B2Dec 30, 2008
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC41 citations92
US7625906B2Dec 1, 2009
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC11 citations83
PHARMAKEA INC
4 patentsUS10150732B2Dec 11, 2018
Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
PHARMAKEA INC10 citations83
US10570094B2Feb 25, 2020
Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
PHARMAKEA INC4 citations72
US11072585B2Jul 27, 2021
Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
PHARMAKEA INC1 citations62
US9850203B2Dec 26, 2017
Autotaxin inhibitor compounds
PHARMAKEA INC0 citations41
JONES ROBERT M
4 patentsUS8410119B2Apr 2, 2013
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JONES ROBERT M8 citations82
US8293751B2Oct 23, 2012
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
JONES ROBERT M8 citations78
US8546429B2Oct 1, 2013
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JONES ROBERT M0 citations51
US8933083B2Jan 13, 2015
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
JONES ROBERT M0 citations46